Bitcoin and Ethereum prices skyrocketed recently due to a 'perfect storm' of falling US Treasury yields, which increased investor appetite for risk assets, and a massive $2.6 billion influx into crypto ETFs. As Bitcoin neared the $80,000 milestone with a 20% gain, Ethereum outperformed with its strongest weekly advance in months, rising 30% as market sentiment shifted toward a more favorable US crypto landscape. The rally was ignited by a combination of macroeconomic shifts and a sudden squeeze on short sellers.
The market movement was further fueled by technical factors, specifically a wave of short liquidations that acted as fuel for the upward price trend. While MicroStrategy’s Michael Saylor maintained his existing massive holdings during this specific 20% jump, Fundstrat’s Tom Lee notably increased exposure to Ethereum even after its 30% surge. This divergence in behavior suggests that while some long-term holders are 'sitting out' the immediate volatility, other institutional players believe the 'catch-up' trade for Ethereum is just beginning.
Macroeconomic factors played a pivotal role in this volatility, as falling Treasury yields lowered the opportunity cost of holding non-yielding digital assets. This coincided with renewed crypto optimism in the United States, where investors are increasingly pricing in a more friendly regulatory framework. The massive $2.6 billion weekly ETF inflow underscores a growing institutional mandate to gain exposure to digital assets as they move into the mainstream financial ecosystem.
Looking ahead, investors should monitor whether Bitcoin can flip the $80,000 level into a firm support zone and if Ethereum’s momentum can sustain its break toward its own previous all-time highs. Key indicators to watch include the daily net flow of spot ETFs and upcoming Federal Reserve commentary regarding interest rate paths, which will directly impact Treasury yields and broader market liquidity. For now, the sentiment remains overwhelmingly bullish as the market absorbs these significant capital injections.